Repositioning Candidate Details
| Candidate ID: | R1061 |
| Source ID: | DB06610 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Omiganan |
| Synonyms: | Omiganan |
| Molecular Formula: | C90H127N27O12 |
| SMILES: | [H]N=C(N([H])[H])N([H])CCC[C@H](N([H])C(=O)[C@H](CCCN([H])C(=N[H])N([H])[H])N([H])C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@H](CCCN([H])C(=N[H])N([H])[H])N([H])C(=O)[C@H](CC(C)C)N([H])C(=O)[C@@H](N([H])[H])[C@@H](C)CC)C(=O)N([H])[C@@H](CCCCN([H])[H])C(=O)N([H])[H] |
| Structure: |
|
| DrugBank Description: | Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections. |
| CAS Number: | 204248-78-2 |
| Molecular Weight: | 1779.183 |
| DrugBank Indication: | Investigated for use/treatment in bacterial infection and rosacea. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|